Axe Compute Inc. (AGPU)

Axe Compute Inc. is a company focused on artificial intelligence computing infrastructure. Its strategy is to acquire rights to GPU computing capacity on the Aethir decentralized cloud network and deploy that capacity to enterprise customers under service contracts, earning revenue from network token rewards and from the difference between its costs and what it bills clients.

The company was formerly known as Predictive Oncology Inc., a business that used artificial intelligence and patient tumor samples to support cancer drug discovery. Axe Compute continues to operate that legacy drug discovery business alongside its newer infrastructure strategy. Its common stock trades on Nasdaq.